Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Blood Research|December 26, 2025
Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromesWan-Hsuan Lee, Chien-Chin Lin, Xavier Cheng-Hong Tsai, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 30, 2025
Molecular Milestones and Survival Outcomes of Ponatinib Treatment in Patients With Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: A Real-World AnalysisTai-Chung Tseng, Yu-Sung Chang, Xavier Cheng-Hong Tsai, et al.
Blood Cancer Journal|September 8, 2018
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemiaFeng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
American Journal of Hematology|March 2, 2023
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemiaMin-Yen Lo, Xavier Cheng-Hong Tsai, Chien-Chin Lin, et al.
Blood Cancer Journal|May 19, 2025
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutationsSao-Chih Ni, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, et al.
American Journal of Hematology|October 12, 2013
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolutionChien-Chin Lin, Hsin-An Hou, Wen-Chien Chou, et al.
American Journal of Hematology|October 16, 2013
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progressionHsin-An Hou, Yuan-Yeh Kuo, Jih-Luh Tang, et al.
American Journal of Hematology|May 22, 2014
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patientsYi-Tsung Yang, Hsin-An Hou, Chieh-Yu Liu, et al.
Blood Cancer Journal|January 22, 2024
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutationsFeng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, et al.
Oncotarget|August 17, 2016
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)Chi-Yuan Yao, Hsin-An Hou, Tzung-Yi Lin, et al.
Pageof 4